Related Experiment Video
Updated: Aug 20, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis
Liang Zhao1, Min Kang1, Xiaomeng Liu1
1Department of Hepatobiliary Surgery and Oncology, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China.
Background:
Glycolysis metabolism is an attractive target for cancer therapy. Reprogramming metabolic pathways could improve the ability of metabolic inhibitors to suppress cancers with limited treatment options. The ubiquitin-proteasome system facilitates the turnover of most intracellular proteins with E3 ligase conferring the target selection and specificity. Ubiquitin protein ligase E3 component N-recognin 7 (UBR7), among the least studied E3 ligases, recognizes its substrate through a plant homeodomain (PHD) finger. Here, we bring into focus on its suppressive role in glycolysis and HCC tumorigenesis, dependent on its E3 ubiquitin ligase activity toward monoubiquitination of histone H2B at lysine 120 (H2BK120ub).
Methods:
In this study, we carried out high-throughput RNAi screening to identify epigenetic candidates in regulating lactic acid and investigated its possible roles in HCC progression.
Results:
UBR7 loss promotes HCC tumorigenesis both in vitro and in vivo. UBR7 inhibits glycolysis by indirectly suppressing HK2 expression, a downstream target of Nrf2/Bach1 axis. Mechanically, UBR7 regulates H2BK120ub to bind to Keap1 promoter through H2BK120ub monoubiquitination, thereby modulating Keap1 expression and downstream Nrf2/Bach1/HK2 signaling. Pharmaceutical and genetic inhibition of glycolytic enzymes attenuate the promoting effect of UBR7 deficiency on tumor growth. In addition, methyltransferase ALKBH5, downregulated in HCC, regulated UBR7 expression in an m6A-dependent manner.
Conclusions:
These results collectively establish UBR7 as a critical negative regulator of aerobic glycolysis and HCC tumorigenesis through regulation of the Keap1/Nrf2/Bach1/HK2 axis, providing a potential clinical and therapeutic target for the HCC treatment.
Insights
UBR7, a ubiquitin ligase, suppresses hepatocellular carcinoma (HCC) by inhibiting glycolysis. Loss of UBR7 promotes HCC, highlighting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Glycolysis is a key target for cancer therapy, especially for cancers with limited treatment options.
- The ubiquitin-proteasome system, involving E3 ligases, regulates protein turnover.
- UBR7, an understudied E3 ligase, plays a role in glycolysis and HCC tumorigenesis via histone modification.
Purpose of the Study:
- To investigate the role of UBR7 in regulating glycolysis and hepatocellular carcinoma (HCC) progression.
- To identify epigenetic regulators of lactic acid metabolism in HCC.
Main Methods:
- High-throughput RNAi screening was employed to identify epigenetic candidates.
- Investigated the mechanism of UBR7's regulation of glycolysis and HCC tumorigenesis.
- Analyzed the impact of UBR7 on histone H2B monoubiquitination (H2BK120ub) and downstream signaling pathways.
Main Results:
- UBR7 loss promotes HCC tumorigenesis in vitro and in vivo.
- UBR7 inhibits glycolysis by suppressing HK2 expression via the Keap1/Nrf2/Bach1 axis.
- UBR7 regulates H2BK120ub, affecting Keap1 expression and downstream signaling.
- ALKBH5 regulates UBR7 expression in an m6A-dependent manner.
Conclusions:
- UBR7 is a critical negative regulator of aerobic glycolysis and HCC tumorigenesis.
- The UBR7-regulated Keap1/Nrf2/Bach1/HK2 axis is crucial for HCC progression.
- UBR7 represents a potential therapeutic target for HCC treatment.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
Inhibition of Cdk Activity
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...